111 related articles for article (PubMed ID: 7509963)
1. Why big endothelin-1 lacks a vasodilator response.
Haleen SJ; Davis LS; LaDouceur DM; Keiser JA
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S271-3. PubMed ID: 7509963
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-B receptor-dependent modulation of the pressor and prostacyclin-releasing properties of dynamically converted big endothelin-1 in the anesthetized rabbit.
Gratton JP; Cournoyer G; D'Orléans-Juste P
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S161-3. PubMed ID: 9595427
[TBL] [Abstract][Full Text] [Related]
3. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.
Pollock DM; Opgenorth TJ
Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752
[TBL] [Abstract][Full Text] [Related]
4. Differential pharmacological profile of endothelin-1 and its precursor, big endothelin.
Le Monnier de Gouville AC; Cavero I
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S362-5. PubMed ID: 1725381
[TBL] [Abstract][Full Text] [Related]
5. Discrimination between ETA- and ETB-receptor-mediated effects of endothelin-1 and [Ala1,3,11,15]endothelin-1 by BQ-123 in the anaesthetized rat.
Bigaud M; Pelton JT
Br J Pharmacol; 1992 Dec; 107(4):912-8. PubMed ID: 1467841
[TBL] [Abstract][Full Text] [Related]
6. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T; Davenport AP; Edvinsson L
Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866
[TBL] [Abstract][Full Text] [Related]
7. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
Allcock GH; Warner TD; Vane JR
Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects of intrathecally administered endothelins and big endothelin-1 in conscious rats: receptor characterization and mechanism of action.
Poulat P; D'Orléans-Juste P; de Champlain J; Yano M; Couture R
Brain Res; 1994 Jun; 648(2):239-48. PubMed ID: 7522926
[TBL] [Abstract][Full Text] [Related]
9. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
Warner TD; Allcock GH; Corder R; Vane JR
Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
[TBL] [Abstract][Full Text] [Related]
10. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
[TBL] [Abstract][Full Text] [Related]
11. Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.
Le Monnier de Gouville AC; Cavero I
Br J Pharmacol; 1991 Sep; 104(1):77-84. PubMed ID: 1786522
[TBL] [Abstract][Full Text] [Related]
12. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
Warner TD; Allcock GH; Vane JR
Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the existence of endothelin-B receptor subtypes and their physiological roles in the rat.
Gellai M; Fletcher T; Pullen M; Nambi P
Am J Physiol; 1996 Jul; 271(1 Pt 2):R254-61. PubMed ID: 8760228
[TBL] [Abstract][Full Text] [Related]
14. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
Zhang Y; Oliver JR; Horowitz JD
Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
[TBL] [Abstract][Full Text] [Related]
15. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.
Ivy DD; Kinsella JP; Abman SH
J Clin Invest; 1994 May; 93(5):2141-8. PubMed ID: 8182146
[TBL] [Abstract][Full Text] [Related]
16. Implication of different endothelin receptors in the vascular action of a hypertensive dose of ET-1 in rat.
Cornet S; Pirotzky E; Braquet P
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S239-42. PubMed ID: 7509955
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a differential location of vasoconstrictor endothelin receptors in the vasculature.
Moreland S; McMullen D; Abboa-Offei B; Seymour A
Br J Pharmacol; 1994 Jun; 112(2):704-8. PubMed ID: 8075891
[TBL] [Abstract][Full Text] [Related]
18. Hyperresponsiveness to ET-1 after treatment with a mixture of ETA and ETB receptor antagonists in the rabbit in vivo and in vitro.
D'Orléans-Juste P; Yano M; Maurice MC; Gratton JP
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S369-72. PubMed ID: 8587417
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of ETB receptors limits the efficacy of nonselective endothelin antagonists in vivo.
Allcock GH; Warner TD
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S177-9. PubMed ID: 8587355
[TBL] [Abstract][Full Text] [Related]
20. A new endothelin receptor antagonist, TAK-044, shows long-lasting inhibition of both ETA- and ETB-mediated blood pressure responses in rats.
Ikeda S; Awane Y; Kusumoto K; Wakimasu M; Watanabe T; Fujino M
J Pharmacol Exp Ther; 1994 Aug; 270(2):728-33. PubMed ID: 8071866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
